What's Happening?
Agilent Technologies Inc. has launched a new multi-attribute method (MAM) workflow aimed at enhancing quality control (QC) in pharmaceutical and biopharmaceutical laboratories. This solution integrates liquid chromatography high-resolution mass spectrometry
(LC/HRMS) into routine, regulated testing environments. The MAM solution combines software, instrumentation, columns, consumables, and standards to overcome operational barriers that have previously limited the use of LC/HRMS in QC settings. It is designed to support the monitoring of critical quality attributes during late-stage development and commercial manufacturing. The workflow is intended to streamline data acquisition, analysis, and reporting, thereby reducing complexity and training requirements while supporting efficient batch release.
Why It's Important?
The introduction of Agilent's MAM solution is significant as it addresses the growing complexity of biologic products and the increasing regulatory expectations for analytical control. As the pharmaceutical industry continues to evolve with advanced modalities like gene therapies and antibody-drug conjugates, there is a heightened demand for analytical techniques that can monitor multiple critical quality attributes in a single method. Agilent's solution aims to meet these demands by providing a comprehensive workflow that integrates into existing QC labs, facilitating method transfer from research and development into manufacturing. This development is crucial for maintaining consistency, reliability, and compliance in the production of complex biologics.
